May 26, 2025 HealthCap V distributes its holding in BONESUPPORT to its limited partners and general partner
May 26, 2025 HealthCap V distributes its holding in BONESUPPORT to its limited partners and general partner
May 20, 2025 Oncopeptides launches new real-world evidence study of Pepaxti in Spain, first patient enrolled
May 14, 2025 Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
May 06, 2025 Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
May 06, 2025 Spruce Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Updates